China Gateway Pharmaceutical

Proton Plan to Acquire 100% Equity of China Gateway Pharmaceutical for RMB 266 Million

Proton shares (300363.SZ) announced that in order to meet the rapid growth of preclinical and early clinical (CRO) business development…